RxDoctor Payments Data

Ellen Bellairs, MD

Radiation Oncology · Maplewood, MNNPI 1952378044

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $20,653 of the $25,168 with a category attached, or 82.1%. Bayer accounts for 93.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $18,405 and has fallen 98.3% since, to $305 in 2025. Among radiation oncology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,168in general payments, 2019–2025

Across 52 payments — averaging $484.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$24K
  • Varian Medical Systems, Inc.$1K
  • Siemens Medical Solutions USA, Inc.$174
  • AbbVie$120
  • Abiomed$101
  • Progenics Pharmaceuticals, Inc.$64
  • plus $105 from 5 others

What the payments were for

  • Speaking & faculty fees$20,65382%
  • Grants$1200%
  • Travel & lodging$3,42214%
  • Food & beverage$9734%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,168 in reported general payments places this provider in the 95th percentile of 128 radiation oncology providers in Minnesota.

See all radiation oncology providers in Minnesota

Medicare billing

Part B allowed, 2024
$752,087
Medicare patients
216
Services billed
4,390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pentoxifylline13$767
Dexamethasone17$561
Lidocaine Hcl ViscousLidocaine Hcl11$205
Tamsulosin Hcl22$178
Azithromycin12$131
Lidocaine-PrilocaineLidocaine/Prilocaine11$130

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Maplewood

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →